Directory

>

Fang Wang

avatar

Fang Wang

Senior Vice President | HotSpot Therapeutics, Inc.

Cambridge, Massachusetts, United States

View contact details (it's free)

Fang Wang

Summary

Fang Wang is a seasoned professional in the oncology field, currently serving as the Senior Vice President of Oncology at Hotspot Therapeutics. With a rich background in drug discovery, Fang has contributed to the development of two FDA-approved oncology medications, Enasidenib and Ivosidenib, and is currently leading a Phase I clinical trial. His expertise spans across antibodies, biomarkers, and tumor immunology, showcasing his commitment to advancing cancer treatment. Fang's career trajectory includes significant roles in various pharmaceutical companies, where he has demonstrated strategic leadership and scientific innovation. He holds a PhD in Molecular Virology from the Chinese Academy of Science and completed postdoctoral studies at UC Berkeley. His passion for oncology is evident not only in his professional achievements but also in his published research, which has contributed to critical advancements in the field.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Organisational experience

Corporate Experience

Fang Wang

Work Experience

company logo

Senior Vice President at

HotSpot Therapeutics, Inc.

February 2023 - Present

company logo

VP of Oncology at

HotSpot Therapeutics, Inc.

January 2021 - February 2023

company logo

VP of Biology at

FogPharma

September 2019 - January 2021

company logo

Director at

Agios Pharmaceuticals

October 2017 - September 2019

company logo

Associate Director/Principal Scientist at

Agios Pharmaceuticals

October 2013 - September 2017

company logo

Sr. Scientist at

Agios Pharmaceuticals

July 2010 - November 2013

company logo

Scientist II at

AVEO Oncology

March 2008 - July 2010

company logo

Research Fellow at

Massachusetts General Hospital

January 2005 - January 2008

company logo

Research Fellow at

Mayo Clinic

November 2002 - April 2005

Logos provided by Logo.dev

Fang Wang

Education

Chinese Academy of Science , Doctor Of Philosophy - Phd

Frequently Asked Questions about Fang Wang

What is Fang Wang email address?

Fang Wang's primary email address is *****@hotspotthera.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Fang Wang work for?

Fang Wang is a Senior Vice President at HotSpot Therapeutics, Inc., a company specializing in Commercial physical research.

Where Fang Wang graduated from?

Fang Wang holds a degree in Molecular Virology from Chinese Academy of Science .

How can I directly contact Fang Wang?

To contact Fang Wang directly, you can use the email address *****@hotspotthera.com. Complete contact information is available upon registration with Muraena.

Who is Fang Wang?

Fang Wang is a seasoned professional in the oncology field, currently serving as the Senior Vice President of Oncology at Hotspot Therapeutics. With a rich background in drug discovery, Fang has contributed to the development of two FDA-approved oncology medications, Enasidenib and Ivosidenib, and is currently leading a Phase I clinical trial. His expertise spans across antibodies, biomarkers, and tumor immunology, showcasing his commitment to advancing cancer treatment. Fang's career trajectory includes significant roles in various pharmaceutical companies, where he has demonstrated strategic leadership and scientific innovation. He holds a PhD in Molecular Virology from the Chinese Academy of Science and completed postdoctoral studies at UC Berkeley. His passion for oncology is evident not only in his professional achievements but also in his published research, which has contributed to critical advancements in the field.

Fang`s contact details

mail

*****@hotspotthera.com

Colleagues

avatar
Paul Thibodeau

Chief Business Officer

avatar
Eva Jack

Chief Operating Officer

avatar
Evan Friedman

Vice President, Development Operations

avatar
Geraldine Harriman

Co-Founder and Chief Scientific Officer

avatar
Hadi Danaee

Vice President and Head, Translational Sciences and Clinical Biomarkers

avatar
Rachel Humphrey Md

Independent Board Director

avatar
David Pelissier

Vice President, Accounting and Corporate Controller

avatar
Stephan Hegge

Vice President Corporate Strategy

avatar
Joe Wahle

SVP, Head of Immunology

avatar
Brian Hamman

Executive Director, Chemical Biology

View Contact details (it's free)
Request Profile Removal